Cargando…
Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: A case report
INTRODUCTION: Well-differentiated systemic mastocytosis (WDSM) is a rare, recently recognized provisional subvariant of systemic mastocytosis (SM). We report a case of WDSM that showed excellent clinical and cutaneous response to imatinib in the absence of known molecular genetic abnormalities. CLIN...
Autores principales: | Huang, Lanshan, Wang, Sa A., Konoplev, Sergej, Bueso-Ramos, Carlos E., Thakral, Beenu, Miranda, Roberto N., Jabbour, Elias, Medeiros, L. Jeffrey, Kanagal-Shamanna, Rashmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072932/ https://www.ncbi.nlm.nih.gov/pubmed/27741105 http://dx.doi.org/10.1097/MD.0000000000004934 |
Ejemplares similares
-
Autoimmune Myelofibrosis and Systemic Lupus Erythematosus in a Middle-Aged Male Presenting Only with Severe Anemia: A case report
por: Pundole, Xerxes, et al.
Publicado: (2015) -
A French National Survey on Clotting Disorders in Mastocytosis
por: Carvalhosa, Ana B., et al.
Publicado: (2015) -
A case of systemic mastocytosis mimicking POEMS syndrome: A case report
por: Hou, Yanqiu, et al.
Publicado: (2022) -
Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients
por: Rouet, Audrey, et al.
Publicado: (2016) -
An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article
por: Wu, Bin, et al.
Publicado: (2017)